申请人:Otsuka Pharmaceutical Company, Limited
公开号:US05385914A1
公开(公告)日:1995-01-31
Method for prophylaxis and treatment of heart diseases using a carbostyril derivative-of formula: ##STR1## wherein R.sup.1 is H or CN, and R.sup.2 and R.sup.3 are each H, alkyl optionally substituted by OH, cycloalkyl, alkenyl, phenyl, phenylalkyl having optionally substituents of alkoxyalkoxy, halogen, alkoxy, NO.sub.2, alkyl, CN, alkylthio or alkylsulfinyl on phenyl ring and having optionally OH-substituent on alkyl moiety, phenylsulfonylalkyl having optionally alkoxy substituent on phenyl ring, phenylthioalkyl, phenylsulfinylalkyl having optionally substituents of halogen or alkoxy on phenyl ring, phenoxyalkyl having optionally substituents of halogen or alkoxy on phenyl ring, pyridylalkyl having optionally substituents of halogen or alkoxy on pyridine ring, thienylalkyl, benzoylalkyl, anilinothiocarbonyl, benzoyl, pyridyl, phenylalkenyl, or group of --A--NR.sup.4 R.sup.5 (R.sup.4 and R.sup.5 are each alkyl or phenyl having optionally substituents of halogen or alkoxy on phenyl ring, and A is alkylene which may be interrupted with O), and a salt thereof, and novel carbostyril derivatives, and pharmaceutical composition for prophylaxis and treatment of heart diseases containing said novel carbostyril derivative.
使用一种羧基苯基吡啶衍生物的方法预防和治疗心脏疾病,其化学式为:##STR1## 其中R.sup.1为H或CN,R.sup.2和R.sup.3分别为H,烷基(可选用OH取代),环烷基,烯基,苯基,苯基烷基,在苯环上可选地带有烷氧基烷氧基,卤素,烷氧基,NO.sub.2,烷基,CN,烷硫基或烷基磺酰基取代基,并在烷基部分上可选地带有OH取代基,苯基磺酰基烷基,在苯环上可选地带有烷氧基取代基,苯基硫基烷基,苯基磺酰基烷基,在苯环上可选地带有卤素或烷氧基取代基,苯氧基烷基,在苯环上可选地带有卤素或烷氧基取代基,吡啶基烷基,在吡啶环上可选地带有卤素或烷氧基取代基,噻吩基烷基,苯甲酰基烷基,苯胺基硫代羰基,苯甲酰基,吡啶基,苯基烯基,或--A--NR.sup.4 R.sup.5(其中R.sup.4和R.sup.5分别为烷基或苯基,苯环上可选地带有卤素或烷氧基取代基,A为可用O中断的烷基),及其盐,以及用于预防和治疗心脏疾病的新型羧基苯基吡啶衍生物和制药组合物。